Filing Details

Accession Number:
0001104659-25-030774
Form Type:
13G Filing
Publication Date:
2025-03-31 20:00:00
Filed By:
Alafi Capital Company, LLC
Company:
Calcimedica Inc. (NASDAQ:CALC)
Filing Date:
2025-04-01
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Alafi Capital Company, LLC 0 1,295,678 9.6%
Christopher D. Alafi 0 1,295,678 9.6%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Row 11: This percentage is calculated based on 13,481,917 outstanding shares of common stock of CalciMedica, Inc. (the "Issuer" or the "Company") as of March 21, 2025, as reported in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission ("SEC") on March 27, 2025 (the "Annual Report").


SCHEDULE 13G



Comment for Type of Reporting Person:  Rows 5, 7: Includes 1,295,678 shares of common stock held by Alafi Capital Company, LLC, for which Mr. Alafi is the managing member and for which he may be deemed to have sole voting or investment power. Row 11: This percentage is calculated based on 13,481,917 outstanding shares of common stock of the Company as reported in the Company's Annual Report.


SCHEDULE 13G


 
Alafi Capital Company, LLC
 
Signature:/s/ Christopher D. Alafi
Name/Title:Christopher D. Alafi, as managing member of Alafi Capital Company, LLC
Date:03/31/2025
 
Christopher D. Alafi
 
Signature:/s/ Christopher D. Alafi
Name/Title:Christopher D. Alafi
Date:03/31/2025
Exhibit Information

Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G